Full Schedule

Speaker: Tadeusz Robak, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Emanuela M. Ghia, PhD – Center for Novel Therapeutics; University of California, San Diego

Primary Author: Yongyi Yuan, MS – Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Co-Author / Presenter: Hao Guo, MD, PhD – Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Primary Author / Presenter: Marco Cellani, MSc – Division of Experimental Oncology, Malignant B cells biology and 3D modelling Unit, San Raffaele Hospital (IRCCS)

Primary Author / Presenter: Pedro Faria Zeni, MSc – Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University

Primary Author / Presenter: Juliana Querol Rivas, PhD student – Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur, Uruguay

Primary Author / Presenter: Patricia Fernández-Guzmán, PhD student – Vall d'Hebron Institute of Oncology (VHIO)

Primary Author: Ya ZHANG, MD – Shandong Provincial Hospital Affiliated to Shandong First Medical University

Co-Author / Presenter: Jun Ma – Shandong Provincial Hospital Affiliated to Shandong First Medical University

Primary Author / Presenter: Gonzalo Blanco, PhD – The Feinstein Institutes for Medical Research

Co-Chair: Marek Mraz, MD, PhD – CEITEC Masaryk University and University Hospital Brno

Co-Chair: Alan G. Ramsay, PhD – Lymphoma Immunology Group, Kings College London

Primary Author / Presenter: Miroslav Boudny, PhD – Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University

Primary Author / Presenter: Hao Guo, MD, PhD – Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Primary Author / Presenter: Britten K. Gordon, BS – The Ohio State University

Primary Author / Presenter: Madhumita Manivannan – University of Alberta

Primary Author: Huayuan Zhu, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University

Co-Author / Presenter: Dan Yang, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University

Primary Author / Presenter: Paul R. Buckley, PhD – King's College London

Primary Author / Presenter: Jodie F. Hay, PhD – University of Glasgow

Primary Author / Presenter: Jiatian Li, PhD student – University of Glasgow

Co-Chair: Philip Thompson, MB, BS (Hons) – Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Co-Chair: Erin M. Parry, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Primary Author / Presenter: Francesco Angotzi, MD – Hematology Unit, University of Padova

Primary Author / Presenter: Laura Ballotta, MD – Hematology Unit, ASUGI Azienda Universitaria Giuliano Isontina, Maggiore Hospital

Primary Author / Presenter: Domitilla Baccon – Department of Hematology, Mayo Clinic

Primary Author / Presenter: Ziyuan Zhou, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University

Co-Chair: Moritz Fürstenau, MD – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne

Co-Chair: Elżbieta Iskierka-Jażdżewska, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital in Lodz, Poland

Primary Author / Presenter: Olina Lind, MSc – Department of Oncology-Pathology, Karolinska Institutet

Primary Author / Presenter: Miguel Bastos-Boente, PhD candidate – Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)

Primary Author / Presenter: Yuting Yan, PhD – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Primary Author / Presenter: Mohammad Al-Agil, MB BCh BAO NUI, MSc – King's College Hospital NHS Foundation Trust

Primary Author / Presenter: Aseel Alsouqi, MD – The Ohio State University

Primary Author: Huayuan Zhu, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University

Co-Author / Presenter: Luomengjia Dai, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University

Primary Author / Presenter: Anita Soboń, MD – Department of Hematology, Institute of Hematology and Transfusion Medicine

Primary Author / Presenter: Collin R. Nzunda, BSc, MPhil – Muhimbili University of Health and Allied Sciences

Co-Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Marek Mraz, MD, PhD – CEITEC Masaryk University and University Hospital Brno

Keynote Speaker: Nicholas Chiorazzi, MD – The Feinstein Institutes for Medical Research, Northwell Health System

Chair: Tadeusz Robak, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Speaker: Iwona Hus, MD, PhD – National Medical Institute of the Ministry of the Interior and Administration

Speaker: Thomas J. Kipps, MD, PhD – UC San Diego, Moores Cancer Center

Co-Chair: Catherine Wu, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Stephan Stilgenbauer, MD – Division of CLL, Internal Medicine III, Ulm University

Speaker: Susan Slager, PhD – Divisions of Hematology and Computational Biology, Mayo Clinic

Speaker: Markus Müschen, MD-PhD – Yale University

Speaker: Frederik Damm, MD – Dept of Hematology, Oncology, & Cancer Immunology, Charité - Universitätsmedizin Berlin

Primary Author / Presenter: Francesco Angotzi, MD – Hematology Unit, University of Padova

Primary Author / Presenter: Emanuela M. Ghia, PhD – Center for Novel Therapeutics; University of California, San Diego

Primary Author / Presenter: Alba Garrote de Barros, MSc – Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041

Primary Author: Uday Aditya Sarkar, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Author / Presenter: Paolo Ghia, MD, PhD – Università Vita Salute and IRCCS Ospedale San Raffaele

Co-Chair: Thorsten Zenz, MD – University of Zurich

Co-Chair: Sarka Pospisilova, PhD – Masaryk University and University Hospital Brno

Speaker: Ferran Nadeu, PhD – Institut d'Investigacions Biomèdiques August Pi i Sunyer

Speaker: Inaki Martin-Subero, PhD – Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Speaker: Fabienne Meier-Abt, MD, PhD – Institute of Medical Genetics, University of Zurich; Department of Medical Oncology and Hematology, University Hospital Zurich

Speaker: Varsha Gandhi, PhD – MD Anderson Cancer Center

Primary Author / Presenter: Helen Parker, PhD – University of Southampton

Primary Author / Presenter: Federico Pozzo, PhD – Centro di Riferimento Oncologico di Aviano

Primary Author / Presenter: Collin R. Nzunda, BSc, MPhil – Muhimbili University of Health and Allied Sciences

Primary Author / Presenter: Martí Duran-Ferrer, PhD – Institut d'Investigacions Biomèdiques August Pi i Sunyer

Co-Chair: Nicholas Chiorazzi, MD – The Feinstein Institutes for Medical Research, Northwell Health System

Co-Chair: Martina Seiffert, PhD – German Cancer Research Center

Speaker: Tanja Nicole Hartmann, Prof., Dr. – Medical Center University Freiburg, Head Research and Clinical Research Coordination, Comprehensive Cancer Center Freiburg

Speaker: Alan G. Ramsay, PhD – Lymphoma Immunology Group, Kings College London

Speaker: Etienne Moussay, PhD – Luxembourg Institute of Health

Primary Author / Presenter: Miroslav Boudny, PhD – Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University

Primary Author / Presenter: Olina Lind, MSc – Department of Oncology-Pathology, Karolinska Institutet

Co-Chair: Paolo Ghia, MD, PhD – Università Vita Salute and IRCCS Ospedale San Raffaele

Co-Chair: Shih-Shih Chen, PhD – The Feinstein Institutes for Medical Research

Speaker: Natarajan (Raj) Muthusamy, DVM, PhD – The Ohio State University

Speaker: Elisa ten Hacken, PhD – Weill Cornell Medicine

Speaker: Tullia Bruno, PhD – The University of Pittsburgh Hillman Cancer Center

Primary Author / Presenter: Chris Pepper, PhD – Brighton and Sussex Medical School

Primary Author / Presenter: Tiana Huynh, MS – City of Hope - Irell and Manella Graduate School of Biological Sciences

Primary Author / Presenter: Shih-Shih Chen, PhD – The Feinstein Institutes for Medical Research

Primary Author / Presenter: Madhumita Manivannan – University of Alberta

Co-Chair: Barbara Eichhorst, MD – Department I of Internal Medicine, University Hospital of Cologne

Co-Chair: William G. Wierda, MD, PhD – The University of Texas MD Anderson Cancer Center

Speaker: Jennifer A. Woyach, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center

Speaker: Nitin Jain, MD – The University of Texas MD Anderson Cancer Center

Primary Author / Presenter: Moritz Fürstenau, MD – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne

Primary Author / Presenter: Thomas Chatzikonstantinou, MD – Institute of Applied Biosciences, Centre for Research and Technology Hellas

Co-Chair: Jennifer R. Brown, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: John Seymour, MBBS, PhD, FRACP – Peter MacCallum Cancer Centre & Royal Melbourne Hospital

Speaker: Inhye E. Ahn, MD – Dana-Farber Cancer Institute

Speaker: Lindsey E. Roeker, MD – Division of Hematology, Mayo Clinic

Speaker: Philip Thompson, MB, BS (Hons) – Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Primary Author / Presenter: Deepa Sampath, PhD – University of Texas MD Anderson Cancer Center

Primary Author / Presenter: Sigrid S. Skånland, PhD – Oslo University Hospital

Primary Author / Presenter: Aseel Alsouqi, MD – The Ohio State University

Co-Chair: Gianluca Gaidano, MD, PhD – University of Eastern Piedmont, Maggiore Charity Hospital

Co-Chair: Silvia Deaglio, MD, PhD – University of Turin

Speaker: Erin M. Parry, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Othman Al-Sawaf, MD PhD – Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital

Primary Author / Presenter: Prajish S. Iyer, PhD – Department of Systems Biology, Beckman Research Institute, City of Hope

Primary Author / Presenter: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON

Co-Chair: Carsten U. Niemann, MD, PhD – Rigshospitalet, Copenhagen University Hospital

Co-Chair: Brian Koffman, MD – CLL Society, Inc., Chula Vista

Speaker: Stephen S. Opat, MBBS – Monash University

Speaker: Tamar Tadmor, MD – Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine

Speaker: Emelie Curovic Rotbain, MD, PhD – Rigshospitalet, Copenhagen University Hospital Danish Cancer Society

Primary Author / Presenter: Alexey V. Danilov, MD, PhD – Department of Hematology and Transplantation, City of Hope National Medical Center

Speaker: Alessandra Ferrajoli, MD – The University of Texas MD Anderson Cancer Center

Speaker: Susan M. O'Brien, MD – Chao Family Comprehensive Cancer Center, University of California

Speaker: Mazyar Shadman, MD, MPH – Fred Hutchinson Cancer Center

Speaker: Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute

Speaker: Susan Geyer, PhD – Mayo Clinic

Speaker: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON

Speaker: Anton W. Langerak, PhD – Erasmus MC, Rotterdam

Speaker: Davide Rossi, MD, PhD – Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI)

Speaker: Eugen Tausch, MD – Division of CLL, Department of Internal Medicine III, University Hospital Ulm and Comprehensive Cancer Center Ulm

Co-Chair: Jennifer A. Woyach, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center

Co-Chair: Francesc Bosch, MD, PhD – Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron

Speaker: Alexey V. Danilov, MD, PhD – Department of Hematology and Transplantation, City of Hope National Medical Center

Speaker: Deborah M. Stephens, DO – Lineberger Comprehensive Cancer Center, University of North Carolina

Speaker: Kerry A. Rogers, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center

Speaker: Jacob Soumerai, MD – Center for Lymphoma, Massachusetts General Hospital Cancer Center, Harvard Medical School

Primary Author: Yongyi Yuan, MS – Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Co-Author / Presenter: Hao Guo, MD, PhD – Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Primary Author / Presenter: Britten K. Gordon, BS – The Ohio State University

Co-Chair: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON

Co-Chair: Maria Teresa Sabrina Bertilaccio, PhD – The University of Texas MD Anderson Cancer Center

Speaker: Parag D. Jasani, MBBS, FRCP, FRCPath – Royal Free London NHS Trust and University College London NHS Trust

Speaker: Helga Simon-Molas, PhD – Amsterdam University Medical Centers

Speaker: J. Joseph Melenhorst, PhD – Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Clinic

Speaker: Sunil Acharya, PhD – The University of Texas MD Anderson Cancer Center

Primary Author / Presenter: Andrew Lu, SB – Dana Farber Cancer Institute

Primary Author / Presenter: Marta Coscia, MD, PhD – Department of Medicine and Surgery, University of Insubria and Department of Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi

Keynote Speaker: Krzysztof Jamroziak, MD, PhD – Medical University of Warsaw

Co-Chair: Anna Schuh, MD, PhD – Churchill Hospital, Oxford University

Co-Chair: Raúl Gabus, MD – Hospital Maciel, ASSE

Primary Author: Raheel Iftikhar, MBBS, FCPS, FRCP, FACP – National University of Medical Sciences, Rawalpindi, Pakistan

Co-Author / Presenter: Tanya Siddiqi, MD – City of Hope Orange County

Speaker: Mazyar Shadman, MD, MPH – Fred Hutchinson Cancer Center

Speaker: Kostas Stamatopoulos, MD, PhD – Institute of Applied Biosciences, Centre for Research and Technology Hellas

Speaker: Catherina Scheepers, MS – The Max Foundation

Speaker: Andrielle Yost, MPA – The Max Foundation

Panelist: Catherine Moura – Brazilian Lymphoma and Leukemia Association (Abrale)

Panelist: Dina Steagall – Brazilian Lymphoma and Leukemia Association (Abrale)

Co-Chair: Thomas J. Kipps, MD, PhD – UC San Diego, Moores Cancer Center

Co-Chair: Michael Hallek, MD, PhD – German CLL Study Group, University Hospital of Cologne

Speaker: Tadeusz Robak, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital